Compare NPCE & GCMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NPCE | GCMG |
|---|---|---|
| Founded | 1997 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 514.3M | 611.5M |
| IPO Year | 2021 | N/A |
| Metric | NPCE | GCMG |
|---|---|---|
| Price | $17.32 | $11.42 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 4 |
| Target Price | ★ $18.00 | $15.25 |
| AVG Volume (30 Days) | 224.5K | ★ 541.3K |
| Earning Date | 11-04-2025 | 02-09-2026 |
| Dividend Yield | N/A | ★ 4.12% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.32 |
| Revenue | $94,864,000.00 | ★ $543,085,000.00 |
| Revenue This Year | $24.82 | $6.58 |
| Revenue Next Year | $0.77 | $9.84 |
| P/E Ratio | ★ N/A | $36.34 |
| Revenue Growth | ★ 24.08 | 17.40 |
| 52 Week Low | $7.56 | $10.23 |
| 52 Week High | $18.98 | $14.48 |
| Indicator | NPCE | GCMG |
|---|---|---|
| Relative Strength Index (RSI) | 66.91 | 49.87 |
| Support Level | $15.03 | $11.25 |
| Resistance Level | $16.33 | $11.93 |
| Average True Range (ATR) | 0.69 | 0.25 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 89.43 | 26.47 |
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.
GCM Grosvenor Inc is a world-wide alternative asset management firm. It invests on behalf of clients who seek allocations to alternative investments, such as private equity, infrastructure, real estate, credit, ESG and absolute return strategies. Company invest maximum in Private Equity. The company's offerings include multi-manager portfolios as well as portfolios of direct investments and co-investments.